Regular Aspirin Use Tied to Lower Risk for Digestive Tract Cancers
Favorable effect increases with longer duration of use, and, for colorectal cancer, with increasing dose.
Diagnosis & Disease Information
Low-Dose Aspirin Administered Twice-Daily Is Optimal for Thrombosis Reduction in Essential Thrombocythemia, Study Finds
Previous mostly retrospective/observational studies evaluated low-dose aspirin administered once daily in the setting of ET. In this study, the more frequent dosing was found optimal.
Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
Risk for 10-year liver-related mortality also lower among aspirin users with chronic hepatitis B or C.
Pregnancy in Myeloproliferative Neoplasms: Aspirin May Raise Likelihood of Live Birth
Researchers examined pregnancy outcomes in 102 patients with essential thrombocythemia.
Aspirin Use May Reduce Cancer, All-Cause Mortality in Seniors
Aspirin use three or more times per week tied to reduced all-cause, cancer, GI cancer, CRC mortality.
Low-Dose Aspirin Does Not Cut Death From Prostate Cancer
But during extended exposure periods of at least five years, low-dose aspirin may cut mortality.
Low-Dose Aspirin May Lower Ovarian Cancer Risk
Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk.
NHS, HPFS Show Regular Aspirin Use Reduced Hepatocellular Carcinoma Risk
An analysis of results from the NHS and the HPFS showed that regular use of aspirin — standard-dose 325-mg tablets — reduced hepacellular carcinoma in a dose-dependent manner.
Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.
Study Determined Association Between Risk of Melanoma, Aspirin Use
In a review of nearly 200,000 patients from a Midwest metropolitan area, researchers sought to determine if chronic aspirin use would offer the same risk reduction for melanoma as has been seen in various cancers.
- Loading...
Loading...
Next post in Melanoma
Loading... 
Loading...